Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials. [electronic resource]
Producer: 20161213Description: 391-400 p. digitalISSN:- 1522-726X
- Aged
- Angina, Stable -- diagnosis
- Angina, Unstable -- diagnosis
- Anticoagulants -- therapeutic use
- Antithrombins -- adverse effects
- Coronary Artery Disease -- diagnosis
- Female
- Hemorrhage -- etiology
- Heparin -- therapeutic use
- Hirudins -- adverse effects
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Peptide Fragments -- adverse effects
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- adverse effects
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.